NO20076463L - Synergetiske kombinasjoner - Google Patents

Synergetiske kombinasjoner

Info

Publication number
NO20076463L
NO20076463L NO20076463A NO20076463A NO20076463L NO 20076463 L NO20076463 L NO 20076463L NO 20076463 A NO20076463 A NO 20076463A NO 20076463 A NO20076463 A NO 20076463A NO 20076463 L NO20076463 L NO 20076463L
Authority
NO
Norway
Prior art keywords
combinations
synergetic
synergetic combinations
pregabalin
carprofen
Prior art date
Application number
NO20076463A
Other languages
English (en)
Norwegian (no)
Inventor
Adrian Paul Foster
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NO20076463L publication Critical patent/NO20076463L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20076463A 2005-05-20 2007-12-14 Synergetiske kombinasjoner NO20076463L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68339105P 2005-05-20 2005-05-20
PCT/IB2006/001655 WO2006123247A2 (en) 2005-05-20 2006-05-18 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands

Publications (1)

Publication Number Publication Date
NO20076463L true NO20076463L (no) 2008-02-11

Family

ID=37102416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076463A NO20076463L (no) 2005-05-20 2007-12-14 Synergetiske kombinasjoner

Country Status (18)

Country Link
US (1) US20080269310A1 (pt)
EP (1) EP1940380A2 (pt)
JP (1) JP2006328067A (pt)
KR (1) KR20080003429A (pt)
CN (1) CN101180045A (pt)
AR (1) AR053733A1 (pt)
AU (1) AU2006248645A1 (pt)
BR (1) BRPI0610316A2 (pt)
CA (1) CA2608010A1 (pt)
EA (1) EA200702280A1 (pt)
IL (1) IL187092A0 (pt)
MA (1) MA29453B1 (pt)
MX (1) MX2007014422A (pt)
NO (1) NO20076463L (pt)
TN (1) TNSN07430A1 (pt)
TW (1) TW200724133A (pt)
WO (1) WO2006123247A2 (pt)
ZA (1) ZA200709830B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
CN108685894B (zh) * 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
ES2880399T3 (es) * 2012-07-27 2021-11-24 Neurodyn Life Sciences Inc Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos
CN105431159B (zh) 2013-05-14 2020-12-01 马斯公司 关节护理组合物
GB201414910D0 (en) * 2014-05-23 2014-10-08 Mars Inc Composition
US9895362B2 (en) 2014-06-16 2018-02-20 Farmacéuticos Rayere, S.A. Pharmaceutical composition combining an anticonvulsant and a derivate of nicotinic acid
MX2014008336A (es) 2014-07-07 2016-01-07 Pptm Internat S A R L Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
MX378004B (es) 2015-12-02 2025-03-10 Jaime Samuel CHAIT AUERBACH Composición oral veterinaria con gabapentina.
EP3907214A1 (en) * 2020-05-04 2021-11-10 Dompe' Farmaceutici S.P.A. Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use
CN113444166A (zh) * 2021-06-24 2021-09-28 深圳市疾病预防控制中心（深圳市卫生检验中心、深圳市预防医学研究所） 卡洛芬人工抗原、抗体及其合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) * 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
DZ2479A1 (fr) * 1997-05-05 2003-02-01 Pfizer Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
CA2608010A1 (en) 2006-11-23
AR053733A1 (es) 2007-05-16
JP2006328067A (ja) 2006-12-07
US20080269310A1 (en) 2008-10-30
TW200724133A (en) 2007-07-01
WO2006123247A2 (en) 2006-11-23
ZA200709830B (en) 2008-12-31
EP1940380A2 (en) 2008-07-09
CN101180045A (zh) 2008-05-14
MX2007014422A (es) 2008-02-11
BRPI0610316A2 (pt) 2010-06-15
MA29453B1 (fr) 2008-05-02
AU2006248645A1 (en) 2006-11-23
WO2006123247A3 (en) 2007-04-26
IL187092A0 (en) 2008-06-05
TNSN07430A1 (fr) 2009-03-17
EA200702280A1 (ru) 2008-04-28
KR20080003429A (ko) 2008-01-07

Similar Documents

Publication Publication Date Title
MX2022004343A (es) Anticuerpos modificados genéticamente como degradadores moleculares a través de receptores celulares.
EA200970483A1 (ru) Применение пролекарств габапентина и прегабалина для лечения шума в ушах
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
DK1957061T3 (da) Kombination omfattende mindst én aminosyre og en PKR-inhibitor til anvendelse i behandlingen af muskelsvind
BRPI0720500A8 (pt) Preparação líquida transdérmica
ATE502629T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl) phenol und einem nsar
BRPI1009860A2 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
PE20120074A1 (es) Composicion que comprende cepa de bacillus subtilis para alimentar animales
BR112013028435A2 (pt) composição para aplicação transdérmica
AR052837A1 (es) Composiciones que contienen hierro
CR11849A (es) Agonistas mezclados, basados en gip para el tratamiento de trastornos metabólicos y obesidad
DOP2017000272A (es) Métodos de diagnóstico para tratamiento con linfocitos t
UA97795C2 (uk) Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
MA29453B1 (fr) Associations synergiques de medicaments anti-inflammatoires non steroidiens avec des ligands d'alpha-2-delta
AR050783A1 (es) Agentes terapeuticos con sal de nsaid y paracetamol
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
CY1115516T1 (el) Φαρμακευτικη συνθεση που περιεχει ενα συνδυασμο ενος μη στεροειδικου αντιφλεγμονωδους παραγοντα και ενος αντισπασμωδικου παραγοντα
CR9200A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos
EA200500941A1 (ru) Средство для лечения болезней суставов
EA200500958A1 (ru) Дейтерированные производные катехоламина, а также лекарственные средства, содержащие эти соединения
EA200500942A1 (ru) Средство для лечения болезней суставов
CL2011000387A1 (es) Combinacion que comprende a) 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y b) paracetamol; forma de dosificacion; uso para tratar osteoartritis y dolor.
NZ598124A (en) Compounds for treatment of inflammation
DOP2016000008A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
CR20120554A (es) Combinación de un aine y un aminoácido

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application